Altered B12 handling and reduced clearance in kidney disease, and both cellular release and reduced clearance in liver disease, can raise B12, so supportive renal or hepatic findings make those causes plausible
Plus a daily research insight email from the lab
no delays, no appointments needed
In appropriate amounts, it promotes vasodilation, enhances blood flow, and supports healing
"Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications." Current Neuropharmacology, 2016;14(8):857-865
Use it only when no more specific modifier applies, specifically XU (Unusual Non-Overlapping Service), XS (Separate Structure), XE (Separate Encounter), or XP (Separate Practitioner)